Design, synthesis and biological evaluation of novel 2,3-dihydroquinazolin- 4(1H)-one derivatives as potential fXa inhibitors

Compound 8e which was designed based on anthranilamide derivative X007 displayed excellent in vivo and in vitro antithrombotic activity and could be considered as a potential fXa inhibitor for the prevention and treatment of thromboembolic diseases.